Wearable Brain-Zapping device aims to ease Period-Related mood and brain fog
NCT ID NCT07679074
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study tests a 12-week digital program called Samphire Guided Care for people with menstrual or pelvic health conditions like PMS, endometriosis, or menopause. The program combines a wearable device that gently stimulates the brain, coaching, and symptom tracking to see if it improves mood, focus, and work productivity. Researchers will measure changes in work impairment and quality of life in 50 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Lutea transcranial direct current stimulation (tDCS) device
What this could lead to
If effective, this program could offer a non-drug, at-home option to ease mood and cognitive symptoms tied to menstruation, perimenopause, or menopause.
What could go wrong
This is a small, early-stage study with only 50 participants and no placebo group, so results may not be generalizable. The device is not FDA-cleared as a medical treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Alethios Digital Research Platform (Decentralized)
RECRUITINGSan Francisco, California, 94105, United States
Contact
Contact Email: •••••@•••••